Full Text View
Tabular View
No Study Results Posted
Related Studies
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001 AM2)
This study is ongoing, but not recruiting participants.
Study NCT00543543   Information provided by Merck

First Received on October 12, 2007.   Last Updated on December 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Cancer
Vulvar Cancer
Vaginal Cancer
Genital Warts
Human Papillomavirus Infection
Additional conditions recognized in this trial
Condylomata Acuminata
Papillomavirus Infections
Uterine Cervical Neoplasms
Vaginal Neoplasms
Vulvar Neoplasms
Warts
More general conditions related to this trial
DNA Virus Infections
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms
Neoplasms by Site
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Viral
Tumor Virus Infections
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Uterine Neoplasms
Vaginal Diseases
Virus Diseases
Vulvar Diseases
Interventions listed in this trial
Comparator: GARDASIL(R)
Experimental: V503
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services